Annual Accounts Receivable
$7.95B$986.18M+14.15%
Summary
- Current Value
- As of today, GSK annual accounts receivable is $7.95B, up +14.15% on
- Historical Performance
- GSK annual accounts receivable is up +21.27% over the past 3 years, up +4.85% over the past 5 years
- All-Time High Comparison
- GSK annual accounts receivable is currently -14.21% below its historical high of $9.27B set on
- 3-Year Low Comparison
- GSK annual accounts receivable is +21.27% above its 3-year low of $6.56B reached on an earlier date
- Sector Comparison
- GSK annual accounts receivable is higher than 97.71% of companies in Healthcare sector
Annual Accounts Receivable Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Accounts Receivable | $7.95B | +14.2% | +21.3% | +4.8% | +6.5% | |
| Quarterly Accounts Receivable | $10.23B | +12.3% | +21.1% | +14.2% | +7.3% | |
| Price | $49.31 | +20.2% | +45.9% | +26.1% | +14.0% | |
| Annual Accounts Payable | $4.75B | +9.7% | +2.2% | -20.2% | +41.9% | |
| Annual Current Assets | $23.55B | +10.6% | -5.7% | -14.9% | -6.2% | |
| Annual Revenue | $43.05B | +7.4% | +19.2% | -1.5% | -1.8% | |
| Annual Net Income | $8.29B | +119.8% | +36.7% | +1.2% | +189.8% | |
| Annual Cash & Cash Equivalents | $4.58B | -6.0% | -51.6% | -47.4% | -53.8% |
Annual Accounts Receivable Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $7.95B | at high | |
| 5Y | $8.46B | -6.0% | |
| All | $9.27B | -14.2% |
Annual Accounts Receivable Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $6.56B | N/A | +21.3% |
| 5Y | $6.56B | +21.3% | |
| All | $381.10M | +1986.9% |
Annual Accounts Receivable History
FAQ
What is the current annual accounts receivable of GSK?
As of today, GSK annual accounts receivable is $7.95B
What is 1-year change in GSK annual accounts receivable?
GSK annual accounts receivable is up +14.15% year-over-year
What is 3-year change in GSK annual accounts receivable?
GSK annual accounts receivable is up +21.27% over the past 3 years
How far is GSK annual accounts receivable from its all-time high?
GSK annual accounts receivable is currently -14.21% below its historical high of $9.27B set on December 31, 2007
How does GSK annual accounts receivable rank versus sector peers?
GSK annual accounts receivable is higher than 97.71% of companies in Healthcare sector
When is GSK next annual earnings release?
As of today, the next annual earnings release for GSK has not been scheduled
Annual Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
Quarterly Accounts Receivable
$10.23B$2.27B+28.60%
Summary
- Current Value
- As of today, GSK quarterly accounts receivable is $10.23B, up +28.60% on
- Historical Performance
- GSK quarterly accounts receivable is up +12.25% year-over-year, up +21.06% over the past 3 years
- All-Time High Comparison
- GSK quarterly accounts receivable is currently -6.38% below its historical high of $10.92B set on
- 3-Year Low Comparison
- GSK quarterly accounts receivable is +46.80% above its 3-year low of $6.97B reached on
- Sector Comparison
- GSK quarterly accounts receivable is higher than 98.21% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Accounts Receivable | $10.23B | +28.6% | +12.3% | +21.1% | +14.2% | |
| Annual Accounts Receivable | $7.95B | – | +14.2% | +21.3% | +4.8% | |
| Price | $49.31 | -16.6% | +20.2% | +45.9% | +26.1% | |
| Quarterly Accounts Payable | $18.90B | -8.6% | -3.3% | +7.2% | -6.2% | |
| Quarterly Current Assets | $23.42B | -0.6% | +0.3% | -3.9% | -8.4% | |
| Quarterly Revenue | $10.28B | -10.3% | +8.6% | +21.7% | +0.5% | |
| Quarterly Net Income | $2.48B | +156.3% | +11.0% | +25.0% | +42.6% | |
| Quarterly Cash & Cash Equivalents | $4.54B | -0.9% | -21.6% | -47.4% | -31.7% |
Quarterly Accounts Receivable Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $10.69B | -4.3% | |
| 3Y | $10.69B | -4.3% | |
| 5Y | $10.69B | -4.3% | |
| All | $10.92B | -6.4% |
Quarterly Accounts Receivable Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $7.95B | +28.6% | |
| 3Y | $6.97B | +46.8% | |
| 5Y | $6.56B | +56.0% | |
| All | $381.10M | +2583.8% |
Quarterly Accounts Receivable History
FAQ
What is the current quarterly accounts receivable of GSK?
As of today, GSK quarterly accounts receivable is $10.23B
What is GSK quarterly accounts receivable most recent change?
GSK quarterly accounts receivable was up +28.60% on March 31, 2026
What is 1-year change in GSK quarterly accounts receivable?
GSK quarterly accounts receivable is up +12.25% year-over-year
How far is GSK quarterly accounts receivable from its all-time high?
GSK quarterly accounts receivable is currently -6.38% below its historical high of $10.92B set on December 31, 2007
How does GSK quarterly accounts receivable rank versus sector peers?
GSK quarterly accounts receivable is higher than 98.21% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk